A narrative systematic review of sexualised drug use and sexual health outcomes among LGBT people
| Autor: | Lorna Porcellato, Matthew Peter Hibbert, Caroline E. Brett, Vivian Hope, Alice Hillis |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Male
medicine.medical_specialty Substance-Related Disorders Sexual Behavior MEDLINE 030508 substance abuse Medicine (miscellaneous) HIV Infections CINAHL PsycINFO law.invention Men who have sex with men 03 medical and health sciences Sexual and Gender Minorities 0302 clinical medicine Condom RA0421 law Outcome Assessment Health Care medicine Humans 030212 general & internal medicine Homosexuality Male Psychiatry Reproductive health research business.industry Health Policy Public health virus diseases Cross-Sectional Studies Pharmaceutical Preparations Female Lesbian 0305 other medical science business Psychology |
| Zdroj: | The International journal on drug policy. 93 |
| ISSN: | 1873-4758 0955-3959 |
| Popis: | Introduction Chemsex is a specific form of sexualised drug use (SDU) that is an emerging public health issue among men who have sex with men (MSM). Although the recent focus on chemsex is a reflection of the associated harms it is important to understand SDU more broadly and its associations with risk behaviours. Additionally, some of the reasons suggested for MSM engagement in SDU are also likely to apply to women who have sex with women (WSW) and trans people. The aim of this review was to investigate SDU, including chemsex, among lesbian, gay, bisexual and trans (LGBT) people internationally in relation to sexual health outcomes (HIV status, STI diagnosis, condom use). Methods Papers that were published between January 2010 and June 2020 reporting SDU in MSM, WSW, or trans people were identified through Medline, PsycINFO, CINAHL Plus and Web of Science. Results were synthesised using a narrative approach. Results The search identified 2,710 publications, of which 75 were included in the final synthesis. The majority of studies measured SDU among MSM (n = 71), and four studies measured SDU among trans people. Research into SDU had been conducted in 55 countries and 32 countries had recorded the use of a chemsex drug among MSM, although the drugs used to define chemsex varied. Among studies that researched MSM, SDU was most commonly investigated in relation to condomless anal intercourse (n = 42), followed by HIV prevalence (n = 35), and then STI diagnoses (n = 27). Drug use was generally associated with sexual health outcomes, but particularly in chemsex studies. Conclusions SDU research is lacking among WSW and trans people, despite trans women having a high HIV prevalence. Among MSM, most drugs were associated with sexual health outcomes, and therefore it is important to include both chemsex drugs and other drugs in SDU research. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect